Gummy vitamins aim to boost hair growth in women

NCT ID NCT07224555

ENROLLING_BY_INVITATION Symptom relief Sponsor: Restore Biologics Holdings, Inc. dba Xtressé Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This pilot study tests whether Xtressé gummy supplements can safely improve hair growth in 60 women aged 18-65 who feel their hair is thinning. Participants take the gummies daily for 4 months, and researchers measure changes in hair density and thickness using special cameras. The goal is to see if this nutraceutical offers a simple way to support hair health.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Xtressé Hair Growth Gummies (plant-based extracts and regenerative compounds)
What this could lead to: If it works, this could point toward a convenient, non-prescription option for women to improve hair density and thickness.
What could go wrong: This is a small, early pilot study with only 60 women, so results may not apply to everyone. The supplement is not a drug and may not produce noticeable changes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HAIR THINNING are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

alopecia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HAIR THINNING

Contacts and locations

Locations

Advanced Dermatology & Cosmetic Surgery

Maitland, Florida, 32751, United States
Hair Medicine Institute

Alpharetta, Georgia, 30005, United States
Kindred Hair and Skin

Marriottsville, Maryland, 21104, United States
Root Hair Institute

Bellevue, Washington, 98004, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.